Dekel D. Bar-Lev

In Vivo Expansion of Cancer Stemness Affords Novel Cancer Stem Cell Targets: Malignant Rhabdoid Tumor as an Example

T. Kalisky, I. Kanter, A. Toren, 2018, Stem cell reports.

Assessing remyelination - metabolic labeling of myelin in an animal model of multiple sclerosis

M. Sela, E. Shezen, R. Arnon, 2016, Journal of Neuroimmunology.

Anti-Tumorigenic Effect of a Novel Derivative of 2-Hydroxyoleic Acid and the Endocannabinoid Anandamide on Neuroblastoma Cells

A. Toren, Tamar Fisher, R. Smoum, 2022, Biomedicines.